Dr. Scheiman Appointed Dean of Research

Mitchell Scheiman, OD, has been appointed dean of Research at Salus University. The announcement was made by University provost, Dr. Janice Scharre, who noted, “Dr. Scheiman’s dedication and experience with research, along with his strong administrative leadership will be an inspiring asset to the Salus Research Department.” 

Dr. Scheiman began his career at the Pennsylvania College of Optometry (PCO) in 1982 and held the position of interim dean of Research prior to this promotion.  Over the years, he has also served as associate dean of Clinical Research and director of the PCO Pediatric/Binocular Vision Programs.  Dr. Scheiman has been recognized nationally for his leadership in binocular vision, serving with such groups as the Department of Defense Clinical Practice Consensus Steering Committee on Vision Pediatric Eye Doctor Investigator group (PEDIG).             

Dr. Scheiman has extensive clinical research extramural funding serving as the co-protocol chair of the National Eye Institute (NEI) of the National Institutes of Health (NIH) Convergence Insufficiency Treatment Study (CITS), and study chair of the NEI Convergence Insufficiency Treatment Trial (CITT).  He recently received approval on his proposed NEI/U10 Cooperative Clinical Research grant entitled the Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART).


Salus University has a history of more than twenty years in the development of an extensive research program in basic and clinical sciences.  The program’s major emphasis is in Biomedical Sciences, Visual Sciences and Clinical Trials. Fundamental research is currently being conducted in a range of areas that span Audiology, Optometry, and Vision Impairment. Salus University researchers are published in such prestigious journals as Neuron, Nature, The Journal of Neuroscience and The Journal of Biochemistry.

Support for research projects at the University comes from the National Science Foundation (NSF), the National Institutes of Health (NIH), the National Eye Institute (NEI), which is part of NIH, and other foundations, such as the Pennsylvania Lions Sight Conservation and Eye Research Foundation and the Pennsylvania Lions Hearing Research Foundation.

Clinical Studies

  • Amblyopia Treatment Studies (ATS)
  • Attention and Perception of Surfaces
  • Receiver-In-The-Ear (RITE)
  • Central Corneal Thickness Study A Prospective of Corneal Thickness in Children Less than 18 Years Old (CCTS)
  • Convergence Insufficiency Treatment Trial – Attention and Reading Study (CITT-ART)
  • Correction of Myopia Evaluation Trial 2 (COMET 2)
  • Collaborative Observational Study of Myopia in COMET Children  (COSMICC)
  • Mechanisms of Near and Intermediate Distance Space Perception
  • Ocular Hypertension Treatment Study (OHTS)
  • Phonetic Context Effects in Cochlear Implant Listeners and Normal Hearing Listeners
  • Retinal Steepness vs. Myopia Development in Children
  • Understanding Encoding of Speech Signal in the Lower Brain Stem: Study Using Human Frequency Following Response (FFR)
  • Vision Rehabilitation Research
  • Vision in Preschoolers (VIP) (completed 2006)

Laboratory Sciences

  • Hafter Laboratory-Guanylate Cyclase Activating Protein (GCAP) in retinal disease
  • Unit of Regulatory & Molecular Biology – Guanylate Cyclase Transduction Mechanisms in Sensory Neurons
  • Visual spatial perception
  • Diabetic retinopathy
  • Retinal pigmentary aging effects
  • Electrophysiology
  • Laser effects
  • Ocular transmittance

For further information about our research programs in general or a particular study, please contact Lydia Parke, Assistant Director of Research at 215 780.1417 or